Pharmacokinetics of norethindrone acetate in women after the insertion of a single subdermal implant releasing norethindrone acetate. 1982

H Singh, and J P Uniyal, and P Jha, and D Takker, and K Murguesan, and V Hingorani, and K R Laumas

The metabolic clearance rate (MCR) of norethindrone acetate (NETA) and norethindrone (NET) levels in plasma were studied after an iv injection of [3H]NETA in three women before and at 1 week, 1, 2 and 6 months following the insertion of a single silastic subdermal implant releasing microquantities of NETA. No significant change in the MCR of NETA was observed at 1 week (459 +/- 72 1/day), 1 month (489 +/- 113 1/day) and 2 months (522 +/- 144 1/day) compared with that of control (525 +/- 108 1/day). However, MCR of NETA showed significant increase in women exposed to continuous presence of NETA for a period of 6 months (608 +/- 121 1/day; P less than 0.025). NETA was rapidly and extensively metabolized into NET. At 1 week, 1, 2 and 6 months of study, NET was observed to be present in higher amounts compared with NETA. The production rate (PR) of progesterone decreased significantly at 2 and 6 months of NETA implant insertion compared with the PR before the insertion of implant.

UI MeSH Term Description Entries
D007700 Kinetics The rate dynamics in chemical or physical systems.
D008657 Metabolic Clearance Rate Volume of biological fluid completely cleared of drug metabolites as measured in unit time. Elimination occurs as a result of metabolic processes in the kidney, liver, saliva, sweat, intestine, heart, brain, or other site. Total Body Clearance Rate,Clearance Rate, Metabolic,Clearance Rates, Metabolic,Metabolic Clearance Rates,Rate, Metabolic Clearance,Rates, Metabolic Clearance
D009640 Norethindrone A synthetic progestational hormone with actions similar to those of PROGESTERONE but functioning as a more potent inhibitor of ovulation. It has weak estrogenic and androgenic properties. The hormone has been used in treating amenorrhea, functional uterine bleeding, endometriosis, and for CONTRACEPTION. 19-Norpregn-4-en-20-yn-3-one, 17-hydroxy-, (17alpha)-,Ethinylnortestosterone,Norethisterone,Norpregneninolone,Conceplan,Micronor,Monogest,Nor-QD,Norcolut,Norcolute,Norethindrone, (1 beta)-Isomer,Norlutin,Nor QD,NorQD
D011374 Progesterone The major progestational steroid that is secreted primarily by the CORPUS LUTEUM and the PLACENTA. Progesterone acts on the UTERUS, the MAMMARY GLANDS and the BRAIN. It is required in EMBRYO IMPLANTATION; PREGNANCY maintenance, and the development of mammary tissue for MILK production. Progesterone, converted from PREGNENOLONE, also serves as an intermediate in the biosynthesis of GONADAL STEROID HORMONES and adrenal CORTICOSTEROIDS. Pregnenedione,Progesterone, (13 alpha,17 alpha)-(+-)-Isomer,Progesterone, (17 alpha)-Isomer,Progesterone, (9 beta,10 alpha)-Isomer
D004343 Drug Implants Small containers or pellets of a solid drug implanted in the body to achieve sustained release of the drug. Drug Implant,Drug Pellet,Pellets, Drug,Drug Pellets,Implant, Drug,Implants, Drug,Pellet, Drug
D005260 Female Females
D006207 Half-Life The time it takes for a substance (drug, radioactive nuclide, or other) to lose half of its pharmacologic, physiologic, or radiologic activity. Halflife,Half Life,Half-Lifes,Halflifes
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000077563 Norethindrone Acetate Acetate ester of norethindrone that is used as a long-term contraceptive (CONTRACEPTIVE AGENTS). Estr-4-en-3-one, 17-(acetyloxy)-17-ethynyl-, (17beta)-,Aygestin,Norethindrone Acetate, (17alpha)-(+-)-isomer,Norethindrone Acetate, (17alpha)-isomer,Norethisterone Acetate,Norlutate
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults

Related Publications

H Singh, and J P Uniyal, and P Jha, and D Takker, and K Murguesan, and V Hingorani, and K R Laumas
December 1978, Contraception,
H Singh, and J P Uniyal, and P Jha, and D Takker, and K Murguesan, and V Hingorani, and K R Laumas
April 1977, Contraception,
H Singh, and J P Uniyal, and P Jha, and D Takker, and K Murguesan, and V Hingorani, and K R Laumas
February 1981, Contraception,
H Singh, and J P Uniyal, and P Jha, and D Takker, and K Murguesan, and V Hingorani, and K R Laumas
October 1977, Contraception,
H Singh, and J P Uniyal, and P Jha, and D Takker, and K Murguesan, and V Hingorani, and K R Laumas
May 1986, Zhongguo yao li xue bao = Acta pharmacologica Sinica,
H Singh, and J P Uniyal, and P Jha, and D Takker, and K Murguesan, and V Hingorani, and K R Laumas
February 1979, Contraception,
H Singh, and J P Uniyal, and P Jha, and D Takker, and K Murguesan, and V Hingorani, and K R Laumas
April 1978, Contraception,
H Singh, and J P Uniyal, and P Jha, and D Takker, and K Murguesan, and V Hingorani, and K R Laumas
September 1991, Contraception,
H Singh, and J P Uniyal, and P Jha, and D Takker, and K Murguesan, and V Hingorani, and K R Laumas
January 1977, Contraception,
H Singh, and J P Uniyal, and P Jha, and D Takker, and K Murguesan, and V Hingorani, and K R Laumas
April 1978, Contraception,
Copied contents to your clipboard!